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There is evidence for defective DNA repair in xeroderma 
pigmentosum, Cockayne's syndrome, and trichothiodys-
trophy, but for increased cancer risk only in xeroderma pig-
mentosum. Natural and adaptive immune surveillance and 
mutant frequency to 6-thioguanine resistance in circulating 
T-lymphocytes were studied in five patients with xeroderma 
pigmemosum. two with Cockayne's syndrome, and one with 
trichothiodystrophy. Forty-eight-hour cutaneous hypersen-
sitivity responses to recall antigens excluded anergy and cir-
culating CD3+, CD4+, CD8+, and CDI6+ cell numbers 
were within normal limits in all patients tested. as were pro-
liferative lymphocyte responses to PHA, except in the tri-
chothiodystrophy patient. Proliferative responses to recall 
antigens (PPD, SKSD, and Candida) showed that all patients 
responded to one or more antigens. Direct natural killercyto-
[Oxiciry measured against the human erythromyeloid leu-
X eroderma pigmcntosum (XP) is a rare recessively inherited disorder characterized by easy. exagger-atcd sunburning, and in some: cases progressive neu-rologic detcrioration and increased susceptibility to cutaneous malignancies [11. Cell fusion studies have 
identified ninc complemcmation groups (A-I) 12 - 7]. Most pa-
tients with XP have a defect in an early step of the excision repai r of 
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Abbrc-viations: 
cs: Cockayne's syndrome 
ONCB: dlnlrrochlorobenz.cne 
LAK: Iymphokllle activated killer 
NK: natural killer 
PHA: phytohaomagglutlnln 
PI)D: tuberculin purified protem dcrivative 
SKSD: snepwkinase/streptodorn.ase 
lTD: rrichothiodystrophy 
UV: ultraViolet 
UVU: ultraviolet-B (280-315 nm) 
XP: xeroderma pigmentosum 
bemia cell line K562 using a 4-h SlCr release assay was 
significantly reduced in xeroderma pigmentosum (specific 
cytotoxicity < mean ± SD > 17.4 ± 9.4 per cent, with ef-
fector : target cell ratio of 50: 1) compared to normal controls 
(45.8 ± 17.8), but normal in Cocbyne's syndrome and tri-
chothiodystrophy. Generation of lymphokine activated 
killer cell activity was normal in the two xeroderma pigmen-
[OSUIll lines teseed. The mutant frequency in tbe xeroderma 
pigmentosum donors was significantly increased (p < 0.01) 
and was elevated in the two Cockaync's syndrome donors. 
taking age into account. No mutants were observed from the 
single trichothiodystrophy donor. These findings suggest 
that reduced natural killer cell activity may contribute to the 
greatly increased susceptibility to skin. cancer in xeroderma 
pigmentosum. } blVfSl D ermalo/ 94:94 -100, 1990 
bulky DNA lesions. such as pyrimidine dimers caused by ultraviolet 
irradiation {B]. This defect in DNA repair is associated with an 
increased UV -induced mutant frequency at the hypoxanthine 
guanine phosphoribosyl transferase locus in fibroblasts, followin~ 
experimental irradiation using 254-nm UV (9.10] and UVB [11 J. 
and a raised mutant frequency in circulating T ~Iymphocytes cul-
tured direcrly from affected individuals (12). 
ft has been proposed chat in addition to an elevated frequency of 
somatic mutations, impaired immune surveillance might be a neces-
sary factor in the development of skin cancer in XP 113]. Various 
defects of adaptive cell mediated immunity have been reported in 
XP, including impaired cutaneous responses to recall antigens 
(14, t 5] and DNCB sensitization [14,16- t B). a decrease in the ratio 
of circulating T helper/suppressor cells [15], and imp. ired lympho-
cyte proliferative responses to phycohaemagglutinin (PHA) 
[14 - 16]. although not al l patients have shown such abnonnalities. 
Morison et al liB] showed that the degree of impairment ofDNCB 
sensitization in XP correlated directly with the severity of cutane-
ous disease, which may reflect in parr the extent of sun exposure or 
the magnitude of any repair defect. However, naroral killer (NK) 
and IYlllphokine activated kjJIer (LAK) cell activity, both important 
mechanisms of immune surveillance [t 9), have not been srodied in 
XP until recently. We now describe in detail defective NK cell 
activity in XP, previously briefly reported [20], and in addition 
report lymphocyte mutant frequencies and details of immune func-
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tion in the parenrs of XP patients and patients with Cockaync's 
syndrome (CS) and trichothiodystrophy (TID). 
The ran~ autosomal recessive gcnodermamses CS and ITO also 
have inherited deficiencies of DNA repair hue have nOt been asso-
ciated with increased cancer risk. In CS. characterized clinically by 
acute sun sensitivity, cachectic dwarfism, pigmentary recinal degen-
eration, and progressive demyelinating neurologic defects. cellular 
sensitivity ro UV [21] is associated with a failure of RNA synthesis 
to recover following irradiation [22]. This has recently been 
ascribed to a specific defect in the repair of actively transcribing 
DNA [23J. In TID, the principal clinical features include ichthyo-
sis, sulphur deficient brittle hair, intellectual impairment, decreased 
fertility, and short scature. Photosensitivity has been described in 
about 50% of cases. A deficiency in excision repair of UV -induced 
damage in fibroblasts from a proportion of patients [24] has been 
recen tly demonstrated. Furthermore, cell fusion studies with cells 
from different XP complementation groups showed that in those 
with a defect in excision repair there was no complementation be-
rween TTD cells and (hose from XP group D 124,251. suggesting a 
similar molecular defect for both conditions. Studies of immune 
function in CS and TTD patients have nor been previously re-
pomd. 
The purpose of this study was to compare natural and adaptive 
immune surveillance in patients with inherited DNA repair defects, 
both with (XP) and without (CS, ITO) associated increased cancer 
risk. We have srudied immune responses by delayed type hypersen-
sitivity skin testing, lymphocyte prolife ration to recall antigens and 
the mitogen PHA. and assessing NK and LAK cell function. 
MATERIALS AND METHODS 
Patients Five chi ld ren with XP, two gi rl s with CS, and a boy with 
TID were studied (Table I) . All were Caucasian English and, ex-
cept the TID patiem, had been protected from sun exposure by 
regular application of high protection factor sunscreens since early 
chi ldhood. No subject had rece ived systemic medication for at least 
two weeks prior to the study. XP was diagnosed in each case by 
measurement of repair of UV-induced damage to fibroblast DNA, 
and the complementation group was determined by cell fusion stud-
ies. CS was di.agnosed by the presence of photosensitivity, growth 
retardation. mental retardation. neurologic deficit, retinal pigmen-
tation. and failure of RNA synthesis to recover following UV expo-
sure of fibroblasts [221. The TID patient [26J demonstrated photo-
sensitivity, generalized ichthyosis, bilateral cararacts, dwarfism, and 
unruly scalp hair of reduced sulphur content. DNA repair studies to 
be presented in detail elsewhere showed a level of unscheduled 
DNA synthesis that was 10%-15% of that in normal ce ll s. 
Lymphocyte subsets and N K activity were also assessed where 
possible in the parents of the XP patients. 
Delayed Type Hypersensitivity Reactions Delayed cutaneous 
hypersensirivity responses of ventral forearm ski n were assessed 
using a multi-head app licator (Multitest C MI , Institut Merieux, 
IMMUNITY IN DNA REPA IR DEFECTIVE GENODERMATOSES 9S 
Lyon, France) [271 preloaded with standardized doses of the recall 
,ntigens tetanus, diphtheria, Streptococcus (group q, tuberculin, 
Co "dido albicans, Trichophyton metltagrophytes, Proteus rnirabilis, and 
glycerin comeol. The scores, expressed in millimeters as the sum of 
induration of all positive sites (> 2 mill) 4S h later, were compared 
with values for a reference population [2S]. 
Cell Preparation Peripheral blood was obtained by venipuncture 
and anticoagulated with 10 U/m! preservative-free heparin (Leo 
Laboratories Ltd., UK). Mononuclear cells were prepared by cen-
trifugation on Lymphoprep density gradients (Nyegaard & Co. 
A.S., Oslo, Norway), washed three times (360 g for 5 min), and 
suspended in RPMI 1640 medium (Gibco) contai'ting 2 mmolJl 
L-glutamine (Gibco), I 00 Jlg/ml penicillin (GI,xo), 40 Jlg/ml gen-
tamicin (Roussel Lab, Ireland), and variab le amounts of heat-inacti-
vated human AS serum o r autologous plasma freed of platelets by 
centrifugation. 
Cell Surface Markers The surface expression of CD3, CD4, 
CDS. and CD 16 on lymphocytes was assessed by Aow cytometry 
using a FACScan (Becton-Dickinson, CA). Mononuclear leuko-
cytes obtained from Lymphoprep centrifugation were incuba ted 
with optimal dilutions ofUCHTl detecting CD3 (kind gift of Dr. 
P. Beverley. Ludwig Institure, Middlesex Hospital), Coulrer Clone 
T4 and T8 detecting CD4 and CDS (Coulter Electronic Ltd., 
Luron, Beds), and OK-NK detecting CD 16 (Ortho Diagnostics. 
NJ) , followed by F1TC-labeled F(ab), fragment of rabbit anti-
mouse antibody (Oakopans). Fluorochrome conjugated and isotype 
matched monoclonal antibodies, which do nor react with human 
lymphocytes, were used to determine non-specific background flu-
orescence. Forward and side scatter gates were set on lymphocytes, 
excluding monocytcs and other leukocytes, and the percentage of 
stai ned cells was determined. 
Absolute numbers of circulat ing lymphocyte subsets were deter-
mined from the hacmatologic full blood count and differential. The 
CD4/CDS ratio was calculated from the percentage ofCD4 stained 
lymphocytes divided by the percenrage of CDS srained lympho-
cytes. 
Lymphocyte Transformation Lymphocyte transformation re-
sponses were assessed [0 1, 10, and 100 Jig/ml of the recall antigens 
Purified Protein Derivative of tuberculin (PPD, Ministry of Agri-
culture and Fisheries, Weybridge, Surrey, UK) and StreptoKinase-
Streptodornase (SKSD. Varidase; Lederle Laboratories, Gosport. 
Hants, UK), and doubling dilutions of 1.25-160 I'g/ml Phytohae-
magglutinin (PHA reagent grade; Welcome Diagnostics, Dartford, 
UK). Mononuclear leukocytes prepared as described above were 
incubated at a final concentration of 5 X 105 ce lls/ml in RI>MI 
(Flow Laboratories. Irvine, Scotland) containing either 10% auro lo-
gous plasma or 10% pooled AD serum in 96-well flat-bottomed 
microtitrc plates (Costar, Cambridge, MA). Cultures were set up ill 
quadruplicate for each dilution of antigen or mitogen. Cells were 
incubated for a total of 6 d for recall antigens and 3 d for PHA in an 
Table J. Clinical Features, DNA Excision Repair. Complementation Group, and Mutation Frequency for Patients Studied 
Neurologic Complementation Mutation frequency to 
Patient Age (yms) Sex Skin cancer abnormalities UOS ('!O) group" 6-TG resist.ance X t 0--6 
XP 
I 7 M 9 0 4.66 
2 12 F 12 G 3.S8 
3 14 M 14 G 7. 11 
4 14 M + 18 0 29.72 
5 16 M sec x 2' + 22 0 10.86 
cs 
I 14 F + 100 N/ A 7.92 
2 14 F + 100 N/ A 7.28 
ITO IS M + IS N/ A <1.02 
• Percent of norm~l unscheduled DNA syntheSlS:U measured in cuhured fibroblasts by :lUlor::adLognphy :after exposure 10 n.di:U1on from 3 g('rmicldli AuorCKcnt !:amp (95% 254 
nm). 
~ sec: squamous cell cucinoma. 
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Table ll. Dc:layed Cutaneous Hypersensitivity Responses 
Indur:lClon response lO intradermal antigen (mm)'" 
POitlent Sex Tnanus Diphtheria Streptococcus Tuberculin 
XP 
2 F 6 3 
3 M 5 3 4 
4 M 8 10 
5 M 5 5 3 
CS 
I F 8 3 4 
2 F 8 
• Mlinufacrurcr's normlll nngc: >10 mm m:a.lcs; >5 mm females. 
atmosphere of 5% CO, in ait at 37"C. Cells were labeled for the 
final 24 h with 0.5 /lCi of methyl-'H-thymidine (2.Ci/mmol. 
Amersham Int.). and uptake of radioactivity was assessed by liquid 
scintillation counting. The PHA dose response curves were com-
pared widl [he range of the response for 10 "ormli adults (ages 
22- 34; five female, five male) to assess abnormal responses to mito-
gens and the possible inhibitory/stimulatory effeers of autologous 
plasma. 
Cytotoxicity Assays Namral killer cell cytotoxicity was mea-
sured against rhe erythromyeloid cell line K-562 in a 4-h slCr 
release assay according to the method of Ortaldo et al [29]. Briefly, 
slCr labeled target cells (104 in 10/11) were admixed with different 
numbers of peripheral blood mononuclear cells (100 ,ul) to achieve 
effector-target cell ratios varying from SO: 1 to 1.5: 1 in 96-well 
microtitre plates, Cell mixtures (containing 5% AD serum, final 
concentration) were incubated in triplicate at 37°C in a 5% CO2-air 
atmosphere, After a 4-11 incubation, the supernatants were harvested 
with the Sk.:aron harvesting system (Sk:aron A.S .. Hierbyen, Nor-
way), and the radioactivity was measured in a comruterized LKB 
gamma countcr. Each test included controls for tota and spontane-
ous isotope release. with maximum release produced by incubation 
of the targets in the presence of 6% sodium dodecyl sulphate (DDH 
Ltd., Poole, England). 
Lymphokine-activated killer cel ls were generated in the presence 
of 2% human All setum by 72 h culture of p<riphe ... 1 blood mono-
nuclear cells (2 X 10'/ml) with 1000 U/ml of recombinant 11.-2 
(Ortho-Phannaceutic.1 Corp., USA). After the incubation, the cells 
were washed 3 rimes with RPMI containing 5% AB serum and 
assessed for their capaciry to lyse the NK-resistant cell line DAUDt 
in a cytotoxic test identical [0 that described for the NK activity, 
Gly«rin Candida 
control albicaru 
3 
Trichophyton 
Prottws 
mi,abilu Sum (mm) 
9 
12 
18 
16 
15 
8 
The degree of NK or LAK cytotoxicity was expressed as the 
percentage of specific lysis which was calculated by the following 
formula: % specific lysis = (cpm test culture - cpm spontaneous 
rclease}/(cpm maximum release - cpm spont2neous release) X 
toO. 
Mutant Frequencies The mutant frequencies to 6-thioguanine 
resistance in circulating T -lymphocytes from peripheral blood sam-
ples were measured by the method described by Cole et .1 [30[. 
RESULTS 
Delayed Cutaneous Hypersensitivity Responses All patients 
with XP and CS tested responded [Q at least one recall antigen and 
had responses expressed as rhe sum of induntion within the manu-
facturers normal range (Table II). Marked ichthyosis precluded test-
ing the pacient with ITO. 
Lymphocyte Subsets Numbers of circulati ng CD3+, CD4+, and 
CDs+ cells were normal in XP (patients and parents) and CS. CD3+ 
numbers wcre at the lower end of the nomlal range in the TTD 
e.atient. CD16+ numbers were normal in the two XP patients tcsted 
(Table III). 
Lymphocyte Proliferative Responses Lymphocytes from all 
patients studied responded by proliferation to one or more doses of 
Cal.JiJa albicatls and SKSD. Patients who gave negative skin test 
responses responded to the higher doses of antigen in the prolifera-
tion tests. Lymphocyte proliferative responses to PHA were within 
the normal range in autologous and AD plasma in XP and CS (Fig 
1). The TTD patient'S resules obtained in aurologous plasma were 
below the normal range and only partially corrected in the presence 
of All plasma. Because this patient 'S lymphocytes responded ro 
Table lli. Circulating Lymphocyte Subsets 
Xeroderma pigmentosum patients 
Xeroderma plg1l1enrosum parents 
Cockayne's syndrome 
TrichothlodystTophy 
Normal mean ±SD 
• ND: I10t donC'. 
Subject no. 
I 
2 
3 
4 
5 
M(I)' 
F(I) 
M(2) 
M(4) 
M(s) 
F(s) 
I 
2 
• M: mother, F: fllher. Figures In p:m:11IhcsIS mdicatC' poHle-nt'S number. 
CD3+ X 10'/1 
1.89 
2.05 
ND 
1.43 
1.54 
1.16 
1.64 
1.37 
0 .92 
1.62 
2.03 
2.40 
2.72 
0.54 
1.50 
0.48 
CD4+ /CD8+ r.l:tio CD16+ (% circulating lymphocytes) 
1.30 NO-
1.53 12 
1.38 18 
1.72 ND 
1.59 ND 
0.72 49 
1.80 19 
1.76 9 
2.04 10 
1.68 II 
2.28 21 
1.3 ND 
2.0 ND 
1.29 ND 
1.89 16 
±O.80 ±s 
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Figure 1. PH A-induced pro l i fe~tion of patients lymphocytes in the pres-
ence of autologous plasma. Uptake oflH-thymidim: is expressed as dpm for 
increasing concent~tions of PHA. Each line represents the results for one 
individuaJ; each point the mean dpm of four replicates for each concentra-
tion of PHA used. Clostd lritlnglt: XPl ; optn tritlnglt: XP2; clostd squart: XP3; 
clostd trianglt: XP4; opt" squtlrt: XP5: optn trianglr: CSt; X: CS2; optn sq lltlrr 
will. do,: 110. The dtlshrJ lina represent the responses of normal individuals 
at the upper (optn cirdt) and lower (closd circlt) limits of the nonnal nnge. 
Ca,.dida albicatlS and SKSO and a control subject and patient XPI 
showed normal lymphocyte proliferation in response to PHA when 
tested in parallel under identical laboratory conditions, it was con-
cluded that these results represented an abnormal response to PHA. 
NK and LAX. Cell Cytotoxicity Table IV shows the percent 
specific NK 2nd LAK cytotoxicity in the various subjects. NK cytO-
toxicity in the XP patients was significantly reduced [17.4% ± 
9.4% speci fic cytotoxicity (me2n ± SO) at effector : target ce ll ratio 
50: tJ compared to 21 normal adults (45.8% ± 17.8%; P < 0.00 1 
unpaired t-test). 12 children with chronic tonsillitis (43.0% ± 
13.0%; p < 0.001), and three normal children aged five, nine, and 
14 years (55.3% ± 19.8%; P < 0.02). Numbers of circulating 
C016+ cells were nonnal in the two XP patients tested. suggesting 
a functional NK defect. NK activiry was also impaired in three of 
the six parents o f XP patients. 
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NK cytotoxicity was within the normaJ range in the two CS 
patients (33.0% ± 4.2%) and the TID patient (60.0%). Results at 
various effector/ target cell ratios are shown in Fig 2. The XP cells 
show a significantly reduced response at all effector/urget cdl 
ratios, whereas the CS and the ITD cells gave a normal response. 
Mutant Frequencies The mutant frequency to 6-thioguanine 
resistance in circulating T-Iymphocytcs from each patient is shown 
in Table I. The mutant frequency for a number of normal children 
(n = 8, age 5 - 17 years) measured during this experimental period 
was 3.84 X 10- 6 ± 0.95 (IS.E). An analys is using the statistical 
package GUM [30J showed that the XP donors had a highly signifi-
cantly raised mutant frequency (p < 0.01). The two CS patients in 
this study also had an elevated mutant frequency for their age. No 
mutants were observed in the single TID donor. 
DISCUSSION 
Studies on the molecular basis of the defect in XP have given strong 
support CO the somatic mutation theory of cancer, in so far as defec-
tive DNA repair results in enhanced sensitivity of cells to mutagen-
esis by UV light [10,11] and is associated with increased sunlight-
induced skin carcinogenesis. An increased mutant frequency has 
also been demonstrated in the circulating T -lymphocytes of XP 
donors it 1] (Table I). On the other hand, in CS, where a different 
defect in DNA repair 121 ] is also correlated with enhanced UV 
mutagenesis in fibroblasts (31] and elevated mutant frequency in 
lymphocytes cultured directly from patients [32J, the absence of an 
increased cancer incidence indicates that this model is nOt suffi cient. 
Burnet [33] originally proposed that the increased cancer suscep-
tibility in XP might result from defective "immunosurveillance" of 
somatic mutations . Evidence consistent with this hypothesis in-
cludes the high incidence of cancer in patients receiving immuno-
suppressive agents for renal transplants [34 ,35] and various other 
disorders [36] and also in patients suffering from immunodeficiency 
conditions 137]. Bridges [13} subsequently argued that in XP the 
d~fects in DNA repair chat confer enhanced mutability to cells are 
not sufficient to account for the increased incidence of cancer and 
proposed that the individuals might have impaired immune surveil-
lance. This suggestion is supported by the impaired cutaneous re-
sponses to recall antigens [14,15]' DNCB sensitization [14,16 - 18J, 
altered T helper/suppressor cell ratios J15J, and impaired lympho-
proliferative responses (14.16] seen in some XP patients. 
W e have demonstrated in five children with XP a marked reduc-
tion in NK activi ty. N ormal circulating numbers of C DI6+ cells in 
Table IV. Direct NK Cytotoxicity and LAK Cell Activity 
Xeroderma pigmentosum p':l ticnts 
Xeroderma pigmentosum parents 
Cockaync's syndrome 
T richothlodystrophy 
Normal adults 
Normal children 
Children with chronic tonsillitis 
Subject no. 
1 
2 
3 
4 
5 
mean ± SO 
M(I¥ 
F(I) 
M(2) 
M(4) 
M(5) 
F(5) 
mean± SO 
1 
2 
me~n ± SD 
mean± SO 
mean ± SO 
mean ± SD 
• NK and LAK actlVlIles are I:Xpreued :u percent specific cytolOlIldty at effector : t':lrgcol cell raflo 50 : 1. 
I N D: not done. 
eM: mother; F: father. Figures In parenthesiS Indicate patient'S number. 
NK activity" UK activity" 
27 NO' 
10 60 
5 59 
24 NO 
21 NO 
17.4 ± 9.4 
34 NO 
16 NO 
16 NO 
20 NO 
31 NO 
IS NO 
22.5 ± 9.5 
30 56 
36 6 1 
33.0 ± 4.2 5S.5 ± 3.5 
64 NO 
45.8 ± 17.8 65.6 ± 13.3 
55.3 ± 19.8 NO 
43.0 ± 13.0 NO 
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Figure 2. Mean ± SE specific cytotoxiciry rOt KS62 cdls at various effec-
tor/ target cdl rarios for normal conrrols (dosed cjrr/f) and patients (open 
eire/t) with xeroderma pigmentosum (aJ. Cockaync's syndrome (b), and 
trichothiodystroph y (eJ. 
the two patients tested indicate a functional NK defect, although 
the ce lls retain their ability to be activated by IL-2. Furthermore. we 
were unable to demonstrate the presence of inhibitory factors for 
lymphocyte proliferation in patients with XP as has been previously 
demonstrated [38]. In contrast to some previous studies [14 - t 8], we 
have not detected any defect in T -cdl mediated responses in our 
sun-protected XP children. 
The lack of a demonstrable abnormal ity of ei ther natural or adap-
tive immunity in rhe CS patients further supports the concept that 
an immunologic defect may be crucial to skin cancer susceptibility 
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Figure 3. Mutant frequency to 6-rhiogu3lline resistance in circulating T-
lym phocytes for children with XP (o~tI square with Jot) and normal children 
(doseJ /riatlgie). 
in XP. The low response of the TID patient to the T-cell mitogen 
PHA probably in part reflects the low percentage of circulating 
CD3+ cells in chis patient. In addition, the observation that cells 
cul tured in AB plasma gave sign ificantly increased results to chose in 
autologous plasma suggests that circulating factors in the serum may 
contribute to the depressed responses seen. 
We have also demonstrated decreased NK activity in some 
asymptomatic XP heterozygotes (parents of patients). A defect in a 
repair process for G2 chromosome damage has been idemified in 
this group [39]. The significance of the defect in some carriers of the 
disease is not at present obvious but suggests that a proportion of 
indiv iduals with such a defect would be present in the normal popu-
lation. 
The mechanism of reduced NK activity in XP is currently unex-
plained. UV radiation has been shown to inhibit NK activity signif-
icanrly both in vitro [40J and in vivo in normal subjects undergoing 
a coursc of solarium exposure [41}. IfNK cell function were particu-
larly UV sensitive, compared with other immune surveillance 
mechanisms. this might explain retention of normal T-cell me-
diated responses in our XP patients in contrast to those found by 
Morison et al [18] for patients living in areas with much higher 
levels of insolation. The possibil ity of a correlation of loss of NK 
activity with level of unscheduled DNA synthesis or existence of 
qualitative differences in immune defects between different XP 
complementation groups merits further study. 
Patients with certain genetic disorders associated with defective 
NK function, such as Chediak Higashi syndtome [42J and X-linked 
Iymphopro liferative syndrome [43], have a very high incidence of a 
fatal lymphoma-like disorder. Low NK cel l cytotoxicity and high 
susceptibility to haemopoietic malignancies is also seen in paroxys-
mal nocturnal haemoglobinuria [44J, Sjogren's syndrome l45], and 
allogenic kidney graft recipicilts with drug induced, long-term NK 
cell depletion [46J, It has therefore been posrulated that NK cells 
operate as effector cells in natural resistance against malignant hae-
mopoietic cells and that they have a ro le in regulation of lympho-
cyte developmem from bone marrow and thymus [47]. 
Immune surveillance is thought to involve both NK cells and 
MH C restricted cells. A deficiency in NK cell numbers or activity 
might therefore be impl icated in the development of malignancy. 
XP patients have a several-thousand-fold increased incidence of the 
cutaneous malignancies squamous ce ll carcinoma, basal cell carci-
noma, and malignant melanoma. There is some evidence for an 
elevated incidence of internal malignancies, possibly including leu-
kaemia r48J, but this is based on case reports and has not been 
subjected to proper epidemiologic analysis. There are no reports of 
lymphomas among XP patients. Our demonstration of selective 
impairment of NK fu nction in XP therefore clearly suggests NK 
cells might be important in skin cancer prevention. Other condi-
tions in which decreased NK activity has been associated with skin 
cancer susceptibility include familial malignant melanoma [49J, 
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Fanconi 's anaemia [501, Cowden's syndrome [5 t I, and chronic lym-
phatic leukaemia [52]. Further. a recent immunohistologic study 
1531 has suggested participation of NK cells as antirumour effector 
ce lls in squamous cell carcinoma. However, it should be noted that 
reduced NK activity in non-malignant conditions, such as atopic 
dermadtis [541 or lepromarous leprosy [551. indicates that impaired 
surveillance by NK cells is not inevitably associated with increased 
cancer risk. Nevertheless, the possible involvement of NK function 
in tumor development ill XP is supported by the fact thac in hyper-
mutab le CS, all immune fUJlctions, including NK activity, arc nor-
mal , and there are no reports of increased cancer incidence. Our 
findings suggest that the greatly increased risk of skin cancer in XP 
may be the result of the combination of an increased rate ofUV-in-
duced mutations in the epidermis and defective immune surveil-
lance, particularly by NK cells. 
IVt art mOlt grattjuf to Dr. F. Ciam'tllijor pumiuiotl to IUt UDS tHid compltmen-
IQli01I data for tht XP patimlJ ami Dr. J. Harper and Dr. D. Athmot,for rtJtrritlg 
tltt ptJtittH luilh ITD. 
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